Problems › The Business Depends Too Much on the Owner › Healthcare Providers
Owner dependence caps the value-based contracts a provider group can accept before it becomes a scheduling issue, and the fix follows one fixed sequence. What makes this harder for healthcare providers is structural: downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it. Any credible answer therefore has to hold cost per episode and payer mix in the same view, which is exactly where most internal analysis stops because the two live in different systems.
Owner dependence caps the value-based contracts a provider group can accept before it becomes a scheduling issue, and the fix follows one fixed sequence. What makes this harder for healthcare providers is structural: downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it. Any credible answer therefore has to hold cost per episode and payer mix in the same view, which is exactly where most internal analysis stops because the two live in different systems.
Provider groups begin with all attributed lives tied to the founding clinician; the measurable question is whether that tie loosens over time. Three layers matter and they must be unwound in order: relationship dependence on the attributed lives, decision dependence on cost-per-episode and payer-mix choices, and knowledge dependence on how those numbers are produced.
Attributed lives move first because they require multiple contract cycles for a patient panel to treat the group, not the individual clinician, as the accountable party. Decision rules come next and consist of writing down the cost-per-episode thresholds and payer-mix targets that have been applied only in conversation. Knowledge transfer is last and amounts to making the underlying episode-cost data visible without the original clinician present.
The common error is to begin by building reports on cost per episode while the same clinician still holds every key relationship and every material decision; the result is a documented operation whose attributed lives and payer-mix choices still require that one person.
In this setting the medical director remains on every high-cost episode review and every new value-based negotiation. That is relationship dependence, visible in the contribution-per-provider numbers, not a missing data dashboard. The sequence stays identical: shift the attributed lives before codifying the decision rules.
These three together are the signature. One on its own usually points somewhere else.
✓ Every material change to panel size, payer mix, or episode-cost target waits for the same individual to approve it.
✓ A measurable share of attributed lives under value-based contracts would leave if the founding clinician departed.
✓ Any period away from daily operations stops new value-based contract discussions and delays payer-mix adjustments.
The move that usually makes it worse. Hiring a second medical director or operations lead before the cost-per-episode and payer-mix rules are explicit, placing the new hire into an undefined decision environment.
It is for you if you run or finance a healthcare provider and meaningful decisions wait for one person. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a healthcare provider. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.
Excerpt from a real Percision run · Customer Value Architecture · sample company profile
The move. Turn $6.8 M downside-risk liability into a $22–35 M licensing platform within 36 months.
The leak it closes. Eliminates $6.8 M downside exposure by enabling proactive utilization management.
The assumption it rests on. Cost-measurement platform achieves <5 % variance versus manual abstraction within 12 months — the engine put the probability at 0.75.
| Investment required | $2.1–3.5 M over 36 months |
| Expected return | 6.3–16.7× cash-on-cash within 36 months based on $196 M current revenue base. |
| Revenue, year 1 | $0 licensing revenue; $1.8 M internal cost avoidance |
| Revenue, year 2 | $4.2 M licensing ARR (40 physicians × $120K + 5 external practices × $400K) |
| Revenue, year 3 | $13.5 M licensing ARR (90 physicians × $120K + 18 external practices × $400K) plus $4–8 M shared-savings upside |
| Exit criteria | Terminate platform investment if variance exceeds 8 % by Month 18 OR if fewer than 40 physicians sign licensing agreements by Month 24; redeploy remaining capital to ASC surgeon-retention track. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Organizational Alignment Model, one of 29 engagements the platform runs. For healthcare providers it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Move relationships first, then decisions, then knowledge. The order matters because relationships take the longest to transfer and are worth the most in any sale.
Substantially, and through the multiple rather than the earnings. A buyer is pricing what survives your departure, so the profit that depends on you is discounted heavily or excluded.
Once the decisions they would own are defined. Hiring one to work out what those are usually ends with the owner doing the job and paying for it twice.
Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית